CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in INCY — Incyte Corp
CIK 884546
SAN FRANCISCO, CA
Position in INCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$191,854,884
+$29,111,804 QoQ
Shares Held
1,692,439
-2.1% QoQ
Ownership
0.847%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#20
of 849 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. INCY ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
This page
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $191,854,884 | 1,692,439 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $162,743,080 | 1,729,102 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $171,132,754 | 1,732,639 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $145,596,804 | 1,716,741 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $113,804,497 | 1,671,138 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $101,846,855 | 1,682,029 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $113,486,637 | 1,643,067 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $106,369,442 | 1,609,220 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $75,474,991 | 1,245,051 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $75,482,914 | 1,324,959 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $83,310,651 | 1,326,814 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $71,010,884 | 1,229,200 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $74,324,010 | 1,193,960 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $83,595,287 | 1,156,708 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $88,754,804 | 1,105,015 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $71,927,017 | 1,079,337 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $81,725,183 | 1,075,756 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $87,695,961 | 1,104,205 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $77,611,838 | 1,057,382 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $68,275,292 | 992,662 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $78,011,140 | 927,269 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $72,573,703 | 892,995 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $80,571,922 | 926,327 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $82,791,252 | 922,568 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $94,137,141 | 905,426 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $69,131,023 | 944,026 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||